12/5
07:44 am
pvla
Rating for PVLA
Low
Report
Rating for PVLA
12/5
07:21 am
pvla
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Low
Report
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
12/5
06:44 am
pvla
Palvella Therapeutics initiated with a Buy at BTIG
Low
Report
Palvella Therapeutics initiated with a Buy at BTIG
12/4
12:51 pm
pvla
Rating for PVLA
Low
Report
Rating for PVLA
12/4
12:51 pm
pvla
Rating for PVLA
Low
Report
Rating for PVLA
12/4
08:04 am
pvla
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Low
Report
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
12/4
08:04 am
pvla
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Low
Report
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
12/4
07:25 am
pvla
Palvella Therapeutics initiated with a Buy at Craig-Hallum
Low
Report
Palvella Therapeutics initiated with a Buy at Craig-Hallum
12/4
07:25 am
pvla
Palvella Therapeutics initiated with a Buy at Craig-Hallum
Low
Report
Palvella Therapeutics initiated with a Buy at Craig-Hallum
11/24
12:34 pm
pvla
Rating for PVLA
Medium
Report
Rating for PVLA
11/19
08:07 am
pvla
Palvella Therapeutics (NASDAQ:PVLA) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating. They now have a $143.00 price target on the stock, up previously from $92.00.
High
Report
Palvella Therapeutics (NASDAQ:PVLA) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating. They now have a $143.00 price target on the stock, up previously from $92.00.
11/19
07:46 am
pvla
Rating for PVLA
High
Report
Rating for PVLA
11/19
07:46 am
pvla
Rating for PVLA
High
Report
Rating for PVLA
11/19
06:44 am
pvla
Palvella Therapeutics upgraded to Strong Buy from Outperform at Raymond James
High
Report
Palvella Therapeutics upgraded to Strong Buy from Outperform at Raymond James
11/19
06:44 am
pvla
Palvella Therapeutics upgraded to Strong Buy from Outperform at Raymond James
High
Report
Palvella Therapeutics upgraded to Strong Buy from Outperform at Raymond James
11/13
09:07 am
pvla
Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $110.00 price target on the stock.
Low
Report
Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $110.00 price target on the stock.
11/13
09:03 am
pvla
Rating for PVLA
Low
Report
Rating for PVLA
11/11
06:02 pm
pvla
Palvella Therapeutics (NASDAQ:PVLA) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Palvella Therapeutics (NASDAQ:PVLA) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
11/7
02:28 pm
pvla
Rating for PVLA
Low
Report
Rating for PVLA
11/6
10:06 am
pvla
Rating for PVLA
Low
Report
Rating for PVLA
10/9
07:49 am
pvla
Rating for PVLA
Medium
Report
Rating for PVLA
10/7
01:02 pm
pvla
Palvella Therapeutics (NASDAQ:PVLA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Palvella Therapeutics (NASDAQ:PVLA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
9/26
07:37 am
pvla
Rating for PVLA
Medium
Report
Rating for PVLA
9/25
10:16 am
pvla
Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Palvella Therapeutics (NASDAQ:PVLA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
9/24
02:20 pm
pvla
Rating for PVLA
Low
Report
Rating for PVLA